Terms: = Ovarian cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
300 results:
1. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
2. Expression of HIF-1α, Ki67, SMA and E-cadherin in endometriosis, endometrial and ovarian carcinoma.
Markov D; Poryazova E; Raycheva R; Markov G
Folia Med (Plovdiv); 2024 Feb; 66(1):97-103. PubMed ID: 38426471
[TBL] [Abstract] [Full Text] [Related]
3. Concomitant [
Kepes Z; Hegedus E; Sass T; Csikos C; Szabo JP; Szugyiczki V; Hajdu I; Kertesz I; Opposits G; Imrek J; Balkay L; Kalman FK; Trencsenyi G
In Vivo; 2024; 38(2):574-586. PubMed ID: 38418132
[TBL] [Abstract] [Full Text] [Related]
4. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
5. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
6. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
7. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
[TBL] [Abstract] [Full Text] [Related]
8. β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway.
Shen J; Ma X; Wei Z; Qian Q; Jing A; Ding Y; Geng T; Qin J; Ma L; Chen Y; Ji J; Liu B; Huang J
Mol Cell Endocrinol; 2024 Mar; 582():112127. PubMed ID: 38109990
[TBL] [Abstract] [Full Text] [Related]
9. Research progress on the mechanism of glycolysis in ovarian cancer.
Li C; Liu FY; Shen Y; Tian Y; Han FJ
Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
[TBL] [Abstract] [Full Text] [Related]
10. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
Li M; Li L; Cheng X; Li L; Tu K
Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
[TBL] [Abstract] [Full Text] [Related]
11. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
Song Y; Li L; Xi Y
Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
[TBL] [Abstract] [Full Text] [Related]
12. Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment.
Gunaydin B; Yigitturk G; Elbe H
Rom J Morphol Embryol; 2023; 64(3):355-361. PubMed ID: 37867353
[TBL] [Abstract] [Full Text] [Related]
13. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
Mori H; Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
Medicine (Baltimore); 2023 Sep; 102(37):e35301. PubMed ID: 37713813
[TBL] [Abstract] [Full Text] [Related]
15. Bromodomain-containing protein 4 activates androgen receptor transcription and promotes ovarian fibrosis in PCOS.
Wang D; Zhu Z; Fu Y; Zhang Q; Zhang Y; Wang T; Weng Y; Wen Y; Cao W; Tao G; Wang Y
Cell Rep; 2023 Sep; 42(9):113090. PubMed ID: 37669164
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming.
Tan S; Yu H; Xu Y; Zhao Y; Lou G
Med Oncol; 2023 Aug; 40(9):272. PubMed ID: 37596446
[TBL] [Abstract] [Full Text] [Related]
18. A novel hypoxia-stimulated lncRNA hif1a-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.
Xie W; Wang W; Meng S; Wu X; Liu X; Liu Y; Kang X; Su Y; Lv X; Guo L; Wang C
Mol Carcinog; 2023 Dec; 62(12):1860-1876. PubMed ID: 37589417
[TBL] [Abstract] [Full Text] [Related]
19. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
Zhou Y; Liu T; Wu Q; Wang H; Sun Y
Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
[TBL] [Abstract] [Full Text] [Related]
20. In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.
Sharma A; Sharma I
Med Oncol; 2023 Jun; 40(7):195. PubMed ID: 37270458
[TBL] [Abstract] [Full Text] [Related]
[Next]
